Skip to main content

Advertisement

Log in

Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

Thrombotic microangiopathy (TMA) has been associated with a large number of underlying diseases. We conducted a descriptive, retrospective study including all TMA adult patients admitted to our ICU, with a particular interest in infectious episodes as a trigger of TMA.

Patients

All adult patients (30) with a diagnosis of TMA admitted to the medical ICU at Saint-Louis Hospital (Paris, France) between 1992 and 1998 were retrospectively included.

Methods

All patients with clinical and microbiological evidence of bacterial infection were treated with intravenous antibiotics. The specific treatment of TMA consisted in solvent/detergent-treated plasma administration by plasma exchange or high volume plasma infusion (30 ml/kg per day) in fractionated doses.

Results

Among the 30 adult patients studied, TMA in 16 (53%) was associated with microbiologically documented infection. An acute infection was found in 8/9 patients with an HIV-related TMA, in 2/6 patients with a systemic lupus erythematosus (SLE)-related TMA and in 3/6 patients with TMA associated with other disorders. In three patients, an acute infectious disease was the only cause associated with the TMA. Four other patients had clinical manifestations suggesting an infection process but without bacteriological documentation. Escherichia coli was isolated in 7/16 cases and verotoxin was found in the stools of two other patients. All patients were treated with plasma administration and those with evidence of infection were systematically and intensively treated with antibiotics. Eventually 8 patients died (27%), 20 (67%) reached complete remission and 2 partial remission.

Conclusion

Bacterial infections are commonly observed amongst TMA patients hospitalized in ICUs and may act as a trigger of this disease. Screening for infection is a requirement in patients with TMA, either idiopathic or associated with other conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Moschowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc 24:21–24

    Google Scholar 

  2. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R (1955) Hämolytisch-urämische syndrome: bilaterale nierenrindennekrosen bei akuten erworbenen hämolytischen anämien. Schweiz Med Wochenschr 85:905–909

    Google Scholar 

  3. Remuzzi G (1987) HUS and TTP: variable expression of a single entity. Kidney Int 32:292–308

    CAS  PubMed  Google Scholar 

  4. Ruggenenti P, Remuzzi G (1998) Pathophysiology and management of thrombotic microangiopathies. J Nephrol 11:300–310

    CAS  PubMed  Google Scholar 

  5. Bell WR, Braine HG, Ness PM, Kichler TS (1991) Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 325:398–403

    Google Scholar 

  6. Rock GA (2001) Management of thrombotic thrombocytopathic purpura. Br J Haematol 109:496–507

    Article  Google Scholar 

  7. Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA and the Canadian Apheresis Group (1991). Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325:393–397

    Google Scholar 

  8. Ruggenenti P, Galbusera M, Plata Cornejo R, Bellevita P, Remuzzi G (1993) Thrombotic thrombocytopenic purpura: evidence that infusion rather than plasma exchanges induces remission of the disease. Am J Kidney Dis 21:314–318

    CAS  PubMed  Google Scholar 

  9. Novitzky N, Jacobs P, Rosenstrauch W (1994) The treatment of thrombotic thrombocytopenic purpura: plasma infusion or exchange? Br J Haematol 87:317–320

    CAS  PubMed  Google Scholar 

  10. Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 47:2–19

    Google Scholar 

  11. Moake JL (1994). Haemolytic-uraemic syndrome: basic science. Lancet 343:393–396

    CAS  PubMed  Google Scholar 

  12. Boyce TG, Swerdlow DL, Griffin P (1995) Escherichia coli O157-H7 and the hemolytic uremic syndrome. N Engl J Med 333:364–368

    Article  CAS  PubMed  Google Scholar 

  13. Fakhouri F, Vincent F, Legendre C (2000) Pathological and therapeutic distinction in HUS/TTP. Lancet 355:497

    Article  CAS  Google Scholar 

  14. Tsai H-M, Lian EC-Y (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585–1594

    PubMed  Google Scholar 

  15. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer V, Mittler U, Solenthaler M, Lämmle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578–1584

    PubMed  Google Scholar 

  16. Moorthy B, Makker SP (1979) Hemolytic-uremic syndrome associated with pneumococcal sepsis. J Pediatr 95:558–559

    CAS  PubMed  Google Scholar 

  17. Myers KA, Marrie TJ (1993) Thrombotic microangiopathy associated with streptococcus pneumoniae bacteremia: case report and review. Clin Infect Dis 17:1037–1040

    CAS  PubMed  Google Scholar 

  18. Toscano V, Bontadini A, Falsone G, Conte R, Fois F, Fabiani A, Mariano VM, Rossi F (1995) Thrombotic thrombocytopenic purpura associated with primary tuberculosis. Infection 23:58–59

    CAS  PubMed  Google Scholar 

  19. Pene F, Papo T, Brudy-Gulphe L, Cariou A, Pitte JC, Vinsonneau C (2001) Septic shock and thrombotic microangiopathy due to Mycobacterium tuberculosis in a non immunocompromised patient. Arch Intern Med 161:1347–1348

    Google Scholar 

  20. Hymes KB, Karpatkin S (1997) Human immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 34:117–125

    CAS  PubMed  Google Scholar 

  21. Marty AM, Dumler JS, Imes G, Brusman HP, Smrkovski LL, Frisman DM (1995) Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation. Hum Pathol 26:920–925

    CAS  PubMed  Google Scholar 

  22. Schröder St, Spyridopoulos I, König J, Jaschonek KG, Luft D, Seif FJ (1995) Thrombotic thrombocytopenic purpura (TTP) associated with a Borrelia burgdorferi infection. Am J Hematol 50:72–73

    Google Scholar 

  23. Riggs SA, Wray NP, Waddel CC, Rossen RD, Gyorkey F (1982) Thrombotic thrombo-cytopenic purpura complicating Legionnaires' disease. Arch Intern Med 142:2275–2280

    CAS  PubMed  Google Scholar 

  24. Shalev O, Karni A, Kornberg A, Brezis M (1981) Thrombotic thrombocytopenic purpura associated with Bacteroides bacteremia. Arch Intern Med 141:692

    CAS  PubMed  Google Scholar 

  25. Scarlett JD, Williamson HG, Dadson PJ, Fassett R, Peel MM (1991) A syndrome resembling thrombotic thrombocytopenic purpura associated with Capnocytophaga canimorsus septicemia. Am J Med 90:127–128

    CAS  PubMed  Google Scholar 

  26. Finn M, Dale B, Isles C (1996) Beware of the dog! A syndrome resembling thrombotic thrombocytopenic purpura associated with Capnocytophaga canimorsus septicemia. Nephrol Dial Transplant 11:1839–1840

    CAS  PubMed  Google Scholar 

  27. Satoh K, Takahashi H, Nagai K, Shibata A (1998) Thrombotic thrombocytopenic purpura and Herpes Zoster infection. Ann Intern Med 108:154–155

    Google Scholar 

  28. Jeejeebhoy FM, Zaltzman JS (1998) Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient. Transplantation 65:1645–1648

    CAS  PubMed  Google Scholar 

  29. Wasserstein A, Hill G, Goldfarb S, Goldberg M (1981) Recurrent thrombotic thrombocytopenic purpura after viral infection. Arch Intern Med 141:685–687

    CAS  PubMed  Google Scholar 

  30. Miniero R, Nesi F, Vai S (1997) Cryptococcal meningitis following a thrombotic microangiopathy in an unrelated donor bone marrow transplant recipient. Pediat Hematol Oncol 14:469–474

    CAS  Google Scholar 

  31. Creager AJ, Brecher ME, Bandarenko N (1998) Thrombotic thrombocytopenic purpura that is refractory to therapeutic plasma exchange in two patients with occult infection. Transfusion 38:419–423

    CAS  PubMed  Google Scholar 

  32. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963

    PubMed  Google Scholar 

  33. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D for the ICU scoring group (1996) The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA 276:802–810

    PubMed  Google Scholar 

  34. Coppo P, Bussel A, Charrier S, Adrie C, Galicier L, Boulanger E, Veyrandier A, Leblanc T, Alberti C, Azoulay E, Le Gall JR, Schlemmer B (2003) High dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Medicine 82:27–38

    Article  CAS  PubMed  Google Scholar 

  35. Patton JF, KR Manning, D Case, J Owen (1994) Serum lactate deshydrogenase and platelet count predict survival in thrombotic thrombocytopenic purpura. Am J Hematol 47:94–99

    CAS  PubMed  Google Scholar 

  36. Light BR (1992) Sepsis syndrome. In: Hall JB, Schmidt GA, Wood LD (eds) Principles of critical care. McGraw-Hill, New York, pp 645–655

  37. Obrig TG, Del Vecchio PJ, Brown JE, Moran TP, Rowland BM, Judge TK, Rothman SW (1988) Direct cytotoxic action of Shiga toxin on human vascular endothelial cells. Infect Immun 56:2373–2378

    CAS  PubMed  Google Scholar 

  38. Keusch GT, Acheson DWK (1997) Thrombotic thrombocytopenic purpura associated with Shiga toxins. Semin Hematol 34:106–116

    CAS  PubMed  Google Scholar 

  39. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E (1996) Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 87:3245–3246

    CAS  PubMed  Google Scholar 

  40. Tannahill CL, Fukuzuka K, Marum T, Abouhamze Z, MacKay SL, Copeland EM 3rd, Moldawer LL (1999) Discordant tumor necrosis factor-alpha superfamily gene expression in bacterial and endotoxemic shock. Surgery 126:349–357

    Article  CAS  PubMed  Google Scholar 

  41. Noris M, Ruggenenti P, Pena A, Orisio S, Caprioli J, Skerka C, Vasile B, Zipfel PF, Remuzzi G (1999) Hypocomplementemia discloses predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. J Am Soc Nephrol 10:281–293

    CAS  PubMed  Google Scholar 

  42. Wong CS, Jelacic SJ, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342:1930–1936

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christophe Adrie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coppo, P., Adrie, C., Azoulay, E. et al. Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients?. Intensive Care Med 29, 564–569 (2003). https://doi.org/10.1007/s00134-003-1676-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1676-4

Keywords

Navigation